Members ( - Mar. 2017 )
Working Members
(JPMA Conference Members and JACL Conference Members: Total 36 Companies)
								Japan Pharmaceutical Manufactures Association (JPMA) Conference Members (28 Companies)
- Asahi Kasei Pharma Corp.
 - Astellas Pharma Inc.
 - Eisai Co., Ltd.
 - Otsuka Pharmaceutical Co., Ltd.
 - Ono Pharmaceutical Co., Ltd.
 - The Chemo-Sero-Therapeutic Research Institute (Kaketsuken)
 - Kaken Pharmaceutical Co., Ltd.
 - Kissei Pharmaceutical Co., Ltd.
 - Kyorin Pharmaceutical Co., Ltd.
 - Kyowa Hakko Kirin Co., Ltd.
 - Shionogi & Co., Ltd.
 - Zeria Pharmaceutical Co., Ltd.
 - Daiichisankyo Co., Ltd.
 
- Sumitomo Dainippon Pharma Co., Ltd.
 - Takeda Pharmaceutical Co., Ltd.
 - Teijin Pharma Limited
 - Toray Industries, Inc.
 - Mitsubishi Tanabe Pharma Corp.
 - Chugai Pharmaceutical Co., Ltd.
 - Toyama Chemical Co., Ltd.
 - Nippon Shinyaku Co., Ltd.
 - Japan Tabacco Inc.
 - Nippon Boehringer Ingelheim Co., Ltd.
 - Pfaizer Japan Inc.
 - Mochida Pharmaceutical Co., Ltd.
 
Other 3 Companies
Japan Association of Contract Laboratories for Safety Evaluation (JACL) (8 Companies)
- Ina Research Inc.
 - Chemicals Evaluation and Research Institute, Japan
 - CMIC Bioresearch Center Co., Ltd.
 - Shin Nippon Biomedical Laboratories, Ltd.
 
- Sumika Chemical Analysis Service, Ltd.
 - Nissei Bilis Co., Ltd.
 - Drug Safety Testing Center Co., Ltd.
 - LSI Medience Corp.
 
Supporting Companies (Total 26 Companies)
- iPS Portal Inc.
 - Agilent Technologies Japan, Ltd.
 - Alphamed Scientific, Inc.
 - Illumina Inc.
 - Scrum Inc.
 - Summit Pharmaceuticals International Corp.
 - Sony Corp.
 - Biolin Scientific K.K.
 - Takara Bio Inc.
 - Takara Bio Euro AB (Cellartis)
 - Novel Science Co., Ltd.
 - Bio Research Center Co., Ltd.
 - Veritas Corp.
 - Soft Sync Inc.
 
- Hamamatsu Photonics K.K.
 - Hitachi High-Technologies Corporation
 - Promega K.K.
 - Molecular Devices Japan K.K.
 - Yokogawa Electric Corp.
 - Reprocell Inc.
 - QIAGEN K.K.
 - Wako Pure Chemical Industries, Ltd.
 - Thermo Fisher Scientific Life Technologies Japan Ltd.
 - Bio Medical Technology HYBRID Co., Ltd.
 - Mitsui & Co., Ltd.
 - Cellular Dynamics International Japan, Inc.
 
Advisory Bords
- Division of Pharmacology, National Institute of Health Sciences (NIHS), 
Head of the Division, Dr. Yuko Sekino (General) - Division of Pharmacology, National Institute of Health Sciences (NIHS), 
Head of Neuropharmacology, Dr. Kaoru Sato (Neurons) - Division of Pharmacology, National Institute of Health Sciences (NIHS), 
Head of Cardiac pharmacology, Dr. Yasunari Kanda (Cardiomyocytes) - Division of Pharmacology, National Institute of Health Sciences (NIHS), 
Head of Hepatopharmacology, Dr. Seiichi Ishida (Hepatocytes) - Graduate School of Pharmaceutical Sciences, Osaka University/National Institute of Biomedical Innovation, 
Professor/Project Leader, Dr. Hiroyuki Mizuguchi (Hepatocytes) - Center for iPS Cell Research and Application (CiRA), Kyoto University, 
Professor, Dr. Haruhisa Inoue (Neurons) - Center for iPS Cell Research and Application (CiRA), Kyoto University, 
Professor, Dr. Kenji Osafune (Hepatocytes) - Center for iPS Cell Research and Application (CiRA), Kyoto University, 
Lecturer, Dr. Yoshinori Yoshida (Cardiomyocytes) 
« Back












